Strong Brain Technology (强脑科技), a leading non-invasive brain-computer interface (BCI) unicorn and part of the famed ‘Hangzhou Six Dragons,’ has confidentially filed for an initial public offering on the Hong Kong Stock Exchange, aiming to raise billions of dollars. The company recently completed a massive funding round of approximately 20 billion RMB, co-led by IDG Capital and Walden International, with participation from industrial giant Lens Technology, marking one of the largest BCI financings globally outside of Neuralink. This IPO filing accelerates the broader ‘Hangzhou Six Dragons’ capitalizing trend, with multiple elite tech startups from the cohort, including Manycore Tech and Unitree, advancing toward public listings in Hong Kong and mainland China. The BCI sector is experiencing heightened investor interest, fueled by technological breakthroughs and competitive dynamics, with China’s market projected to grow at 20% annually, offering significant opportunities for institutional investors. Strong Brain Tech’s move is a key indicator of the commercial viability of BCI technology, positioning it as a formidable competitor to U.S. leaders like Neuralink and highlighting the strategic importance of the Hangzhou Six Dragons capitalizing wave in global tech innovation.
Hangzhou’s ‘Six Dragons’ Capitalization Surge: Brain-Computer Interface Unicorn Strong Brain Tech Files Confidential Hong Kong IPO
